OTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
Quality Choice No Drip nasal decongestant is being recalled due to a manufacturing deviation in water purification. No contamination was detected in the finished products.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a FDA Class II voluntary precautionary recall based on a manufacturing deviation with no contamination detected in finished products and no reported illnesses or injuries.
Plain-English summary
Seaway Pharma Inc. is recalling Quality Choice No Drip Extra Moisturizing Nasal Pump Mist (Oxymetazoline hydrochloride 0.05%) due to a manufacturing deviation. The firm reported possible microbial contamination in the purified water used during manufacturing. However, no contamination was found in any of the finished products.
The recall affects 7,992 bottles of Lot SE23034 with expiration date 05/31/2026, distributed in Michigan and Pennsylvania. The affected product is 1 fl oz (30 mL) bottles with NDC# 63868-676-01 and UPC 6-35515-98847-7.
Consumers who have this product should not use it and should contact their pharmacy, healthcare provider, or distributor for instructions on return or disposal.
The recalled product
- Product
- OXYMETAZOLINE HYDROCHLORIDE (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- OXYMETAZOLINE HYDROCHLORIDE
- Manufacturer
- Seaway Pharma Inc.
- Category
- Drug — OTC Nasal Decongestant
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # SE23034
- Exp 05/31/2026
UPCs (3)
- 0635515988439
- 0635515988477
- 635515988477
Distribution
Distributed in 2 states:
- MI
- PA
Related recalls
Same brand · OXYMETAZOLINE HYDROCHLORIDE
- ModerateNasal Decongestant Recalled for Possible Manufacturing Water Contamination
FDA (Drugs) · 2024-01-10
- ModerateOxymetazoline Nasal Spray Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27